GSK has received approval from Japan’s MHLW for RSV vaccine Arexvy to prevent RSV disease in adults aged over 60 years ...

The European Medicines Agency (EMA) and the European Centre for Disease Control (ECDC) recommend targeting people at risk in ...

New RSV vaccines are now available to help prevent serious infection in people over 60. Doctors explain the RSV vaccine and ...

GSK plc has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Arexvy (respiratory ...

The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...

New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...

Updated COVID-19 vaccines are being rolled out in the U.S., aimed at targeting the latest, prevalent variants of the disease.

GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare ...

Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, that can help to protect infants through the active immunisation of pregnant women, has been backed by the US Centers for Disease Control ...

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...

In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to ...

GSK’s Arexvy receives Japanese regulatory approval for prevention of respiratory syncytial virus disease for older adults: London, UK Tuesday, September 26, 2023, 10:00 Hrs [IST ...